Internal Medicine, Medical Oncology · Fairfax, VA
NPI
1881602027
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
8081 Innovation Park Dr
Fairfax, VA, 22031
Phone (571) 472-4724
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
664 services
Medicare patients, 2024
342
Average age 75
Drug cost, 2024
$1.4M
1,311 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia C Rizzo was code 99214 (office e&m - established), 347 times for 236 patients. In total Patricia C Rizzo billed 664 services in 12 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 347 | 236 | $72.51 | $25K |
| 99215 Office E&M - Established | Office | 173 | 48 | $117.37 | $20K |
| 99205 Office E&M - New | Office | 33 | 33 | $147.77 | $4,876 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 17 | $101.21 | $2,227 |
| 99222 Hospital E&M - Initial | Facility | 21 | 21 | $105.80 | $2,222 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 16 | $66.32 | $1,194 |
| 99213 Office E&M - Established | Office | 17 | 17 | $40.58 | $690 |
| 99204 Office E&M - New | Office | 13 | 13 | $88.30 | $1,148 |
By year: 2022 $84K for 884 services; 2023 $75K for 789 services; 2024 $60K for 664 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia C Rizzo prescribed most often to Medicare patients was Letrozole, with 589 prescriptions and refills. In total Patricia C Rizzo wrote 1,311 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 589 | 1,648 | 183 | $17K |
| Exemestane Generic | 140 | 361 | 39 | $22K |
| Tamoxifen Citrate Generic | 105 | 310 | 33 | $3,178 |
| Anastrozole Generic | 67 | 177 | 18 | $1,069 |
| Ibrance Palbociclib | 43 | 43 | Under 11 | $677K |
| Dexamethasone Generic | 30 | 35 | 17 | $427 |
| Prochlorperazine Maleate Generic | 27 | 27 | 15 | $262 |
| Ondansetron Hcl Generic | 23 | 23 | 18 | $196 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 22 | 22 | 15 | $234 |
| Zarxio Filgrastim-Sndz | 21 | 21 | Under 11 | $37K |
| Eliquis Apixaban | 18 | 32 | Under 11 | $17K |
| Raloxifene Hcl Generic | 17 | 43 | Under 11 | $897 |
| Verzenio Abemaciclib | 15 | 15 | Under 11 | $229K |
| Lynparza Olaparib | 13 | 13 | Under 11 | $211K |
| Sucralfate Generic | 12 | 12 | Under 11 | $900 |
Brand drugs: 174 claims; generic drugs: 1,137 claims; opioid claims: 17.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Patricia C Rizzo were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.